Dr. Liow is the Director of Hawaii Pacific Neuroscience, Chair of the Dept. of Medicine at Castle Medical Center and Clinical Professor of Neurology at the University of Hawaii John Burns School of Medicine.
Dr. Liow completed his residency training at the University of Utah School of Medicine and research fellowship at US National Institute Neurological Disorders and Stroke, NIH (National Institutes of Health), in Bethesda, Maryland. After NIH, he went on to establish and directed one of the busiest neuroscience clinical trial programs in the Midwest US and rose through the academic ranks to Professor of Neurology at the University of Kansas medical school. He served as an investigator for over 40 neuroscience clinical trials sponsored by the NIH, CDC and others. He is a nationally recognized leader in the neuroscience field, having published over 40 peer reviewed publications in neuroscience, served on the national advisory panel for the CDC, American College of Physicians and American Academy of Neurology and drafted national position statements for these national organizations.
Hawaii Pacific Neuroscience (HPN) Center is one of Hawaii's largest providers of neuroscience care, having served over 24,000 patient visits in 2014 from all Hawaiian Islands. HPN is committed to these patients who come from all corners of the Pacific to seek the most advanced care and research treatments in dementia, which are provided by Hawaii's top specialists in the fields of Neurology, Neuro-rehabilitation, Geriatrics, Psychiatry, Neuropsychology, Psychology and Behavioral Science who rely on a holistic, fully-integrated, multidisciplinary patient-centered care model. HPN leads the state in bringing dementia clinical trials to the islands with a dedicated Research and Clinical Trial Unit and research hotline so that Hawaiian patients do not have to travel to the mainland to seek these advanced research treatments. HPN physicians are some of the most experienced and seasoned researchers in dementia and have been involved in the clinical trial and development of many new therapies in neuroscience.